Mortality Following Cardiovascular and Bleeding Events Occurring Beyond 1 Year After Coronary Stenting: A Secondary Analysis of the Dual Antiplatelet Therapy (DAPT) Study.

about

Mortality Following Cardiovascular and Bleeding Events Occurring Beyond 1 Year After Coronary Stenting: A Secondary Analysis of the Dual Antiplatelet Therapy (DAPT) Study.

Item

http://www.wikidata.org/entity/Q38379410

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Mortality Following Cardiovasc ...... platelet Therapy (DAPT) Study.

@en

type

Item

label

Mortality Following Cardiovasc ...... platelet Therapy (DAPT) Study.

@en

prefLabel

Mortality Following Cardiovasc ...... platelet Therapy (DAPT) Study.

@en

P1476

Mortality Following Cardiovasc ...... platelet Therapy (DAPT) Study.

@en

P2093

Christopher P Cannon

http://www.w3.org/2001/XMLSchema#string

David J Cohen

http://www.w3.org/2001/XMLSchema#string

Dean J Kereiakes

http://www.w3.org/2001/XMLSchema#string

Donald E Cutlip

http://www.w3.org/2001/XMLSchema#string

Dual Antiplatelet Therapy (DAPT) Study Investigators

http://www.w3.org/2001/XMLSchema#string

Eric A Secemsky

http://www.w3.org/2001/XMLSchema#string

Joseph M Massaro

http://www.w3.org/2001/XMLSchema#string

Laura Mauri

http://www.w3.org/2001/XMLSchema#string

Patricia K Apruzzese

http://www.w3.org/2001/XMLSchema#string

Ralph B D'Agostino

http://www.w3.org/2001/XMLSchema#string

P2860

An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators

Evaluating the generalizability of a large streamlined cardiovascular trial: comparing hospitals and patients in the dual antiplatelet therapy study versus the National Cardiovascular Data Registry.

Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention.

Impact of the everolimus-eluting stent on stent thrombosis: a meta-analysis of 13 randomized trials.

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventi

Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial.

Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents

Antiplatelet therapy duration following bare metal or drug-eluting coronary stents: the dual antiplatelet therapy randomized clinical trial

Balancing Long-Term Risks of Ischemic and Bleeding Complications After Percutaneous Coronary Intervention With Drug-Eluting Stents.

Benefits and Risks of Extended Duration Dual Antiplatelet Therapy After PCI in Patients With and Without Acute Myocardial Infarction.

P304

478-487

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/JAMACARDIO.2017.0063

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Philippe Gabriel Steg

P577

2017-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28297015

http://www.w3.org/2001/XMLSchema#string

P932

5814981

http://www.w3.org/2001/XMLSchema#string